Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 422.92M | $ 63.04M | 14.91% |
3/31/2025 | $ 469.67M | $ 38.58M | 8.21% |
12/31/2024 | $ 547.22M | $ 31.8M | 5.81% |
9/30/2024 | $ 622.43M | $ 97.63M | 15.68% |
6/30/2024 | $ 697.11M | $ 92.84M | 13.32% |
3/31/2024 | $ 767.6M | $ 87.86M | 11.45% |
12/31/2023 | $ 882.28M | $ 84.3M | 9.55% |
9/30/2023 | $ 949.66M | $ 9.87M | 1.04% |
6/30/2023 | $ 1.08B | $ 9.61M | 0.89% |
3/31/2023 | $ 1.22B | $ 8.64M | 0.71% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for SAGE THERAPEUTICS INC is calculated as follows: GP [ $ 6.33M ] / Assets [ $ 738.63M ]
(=) GPA [ 0.86% ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.95% |